In the U.K. Cluster Randomized Trial for PSA Testing for Prostate Cancer (CAP), more than 400,000 men in primary care practices between 2001 and 2009 were either invited to receive a single PSA screening test or usual care. After a median follow-up of 10 years
Reducing harms associated with PSA screening
Reducing harms associated with PSA screening
Reducing harms associated with PSA screening
In the U.K. Cluster Randomized Trial for PSA Testing for Prostate Cancer (CAP), more than 400,000 men in primary care practices between 2001 and 2009 were either invited to receive a single PSA screening test or usual care. After a median follow-up of 10 years